This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Why Index Levels Matter explains the impact of index readings on market perception and strategy, guiding you to smarter investment choices.
23,403 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
In a choppy market, dividend stocks double right by combining reliable income with growth potential. This guide highl...
Micron's stock jumped more than 600% in a year, sparking a lively debate about a possible stock split. This guide bre...
Tax policy debates often clamp down on the top earners, but targeting high earners misguided choices can undermine st...
Two AI models weigh in on whether SpaceX’s high-profile IPO will boost or drag Bitcoin in the near term. The verdict ...
As conflicts persist around the globe, households feel the bill. Experts say the true cost goes beyond weapons, shapi...
Buffett’s longest-running wager sits in plain sight: a simple, legendary drink that built a fortress around its brand...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
Agentic rising fast AI is changing how businesses operate, not just how we talk to machines. This article analyzes So...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Michigan drivers are feeling the pinch as gas prices rise. This article explains the root causes, the economic ripple...
Brady Corporation has captured market attention with a rapid rally. Learn what’s driving shares brady corporation soa...